KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Change in Inventory (2016 - 2026)

Amgen has reported Change in Inventory over the past 18 years, most recently at -$18.0 million for Q1 2026.

  • For Q1 2026, Change in Inventory rose 93.75% year-over-year to -$18.0 million; the TTM value through Mar 2026 reached -$616.0 million, up 69.41%, while the annual FY2025 figure was -$886.0 million, 65.01% up from the prior year.
  • Change in Inventory for Q1 2026 was -$18.0 million at Amgen, up from -$119.0 million in the prior quarter.
  • Over five years, Change in Inventory peaked at $241.0 million in Q3 2022 and troughed at -$806.0 million in Q1 2024.
  • A 5-year average of -$187.4 million and a median of -$119.0 million in 2025 define the central range for Change in Inventory.
  • Biggest five-year swings in Change in Inventory: surged 402.08% in 2022 and later plummeted 2306.67% in 2024.
  • Year by year, Change in Inventory stood at $91.0 million in 2022, then crashed by 729.67% to -$573.0 million in 2023, then surged by 43.63% to -$323.0 million in 2024, then soared by 63.16% to -$119.0 million in 2025, then surged by 84.87% to -$18.0 million in 2026.
  • Business Quant data shows Change in Inventory for AMGN at -$18.0 million in Q1 2026, -$119.0 million in Q4 2025, and -$240.0 million in Q3 2025.